Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice

Age

Volumn 32, Issue 3, 2010, Pages 271-282

  Ahmad, Abdullah Shafique ^a   Ahmad, Muzamil ^a   Maruyama, Takayuki ^b   Narumiya, Shuh ^c   Doré, Sylvain ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ONO PHARMACEUTICAL CO   (Japan)

^c KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

BW245C; G protein coupled receptors; Mouse; Neurodegeneration; Neuroprotection; NMDA; Prostaglandins

Indexed keywords

5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; N METHYL DEXTRO ASPARTIC ACID; PROSTAGLANDIN D2; PROSTAGLANDIN D2 RECEPTOR 1; PROSTAGLANDIN RECEPTOR; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; PROSTAGLANDIN D2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE MEASUREMENT; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; CORE TEMPERATURE; EXCITOTOXICITY; GENE DELETION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; PHARMACOLOGICAL STIMULATION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; WILD TYPE; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; METABOLISM; MOUSE MUTANT; STROKE;

ANIMALS; BRAIN ISCHEMIA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROSTAGLANDIN D2; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; STROKE;

EID: 77956183759     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-010-9135-y     Document Type: Article

References (70)

1. MS Abdel-Halim M Hamberg B Sjoquist E Anggard 1977 Identification of prostaglandin D2 as a major prostaglandin in homogenates of rat brain Prostaglandins 14 633 643 10.1016/0090-6980(77)90190-3 10.1016/0090-6980(77) 90190-3 1:CAS:528:DyaE1cXhvFGgug%3D%3D 594367
2. M Abramovitz M Adam Y Boie M Carriere D Denis C Godbout S Lamontagne C Rochette N Sawyer NM Tremblay, et al. 2000 The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs Biochim Biophys Acta 1483 285 293 10.1016/S1388-1981(99)00164-X 1:CAS:528:DC%2BD3cXjt1equw%3D%3D 10634944
3. AS Ahmad S Saleem M Ahmad S Doré 2006 Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage Toxicol Sci 89 265 270 10.1093/toxsci/kfj022 10.1093/toxsci/kfj022 1:CAS:528:DC%2BD2MXhtlagtLfM 16237196
4. AS Ahmad H Zhuang V Echeverria S Doré 2006 Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity J Neurotrauma 23 1895 1903 10.1089/neu.2006.23.1895 10.1089/neu.2006.23.1895 17184197
5. 1 reduces infarction volume in mouse transient cerebral ischemia Eur J Neurosci 23 35 42 10.1111/j.1460-9568.2005. 04540.x 10.1111/j.1460-9568.2005.04540.x 16420413
6. K Alving R Matran JM Lundberg 1991 The possible role of prostaglandin D2 in the long-lasting airways vasodilatation induced by allergen in the sensitized pig Acta Physiol Scand 143 93 103 10.1111/j.1748-1716.1991.tb09204.x 10.1111/j.1748-1716.1991.tb09204.x 1:CAS:528:DyaK3MXmt1Cls74%3D 1957709
7. V Angeli D Staumont AS Charbonnier H Hammad P Gosset M Pichavant BN Lambrecht M Capron D Dombrowicz F Trottein 2004 Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses J Immunol 172 3822 3829 1:CAS:528:DC%2BD2cXhvVKitrg%3D 15004188
8. M Banay-Schwartz A Lajtha M Palkovits 1989 Changes with aging in the levels of amino acids in rat CNS structural elements. I. Glutamate and related amino acids Neurochem Res 14 555 562 10.1007/BF00964918 1:CAS:528: DyaL1MXltlWnsb8%3D 2761674
9. E Bohm GJ Sturm I Weiglhofer H Sandig M Shichijo A McNamee JE Pease M Kollroser BA Peskar A Heinemann 2004 11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils J Biol Chem 279 7663 7670 10.1074/jbc.M310270200 10.1074/jbc.M310270200 14668348
10. RS Bresalier RS Sandler H Quan JA Bolognese B Oxenius K Horgan C Lines R Riddell D Morton A Lanas, et al. 2005 Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial N Engl J Med 352 1092 1102 10.1056/NEJMc066260 10.1056/NEJMoa050493 1:CAS:528:DC%2BD2MXit1Kqu7o%3D 15713943
11. R Brus ZS Herman R Szklinik 1980 Central effects of prostaglandin D2 Pol J Pharmacol Pharm 32 681 684 1:CAS:528:DyaL3MXktVSktLg%3D 7267458
12. IG Campbell I Feinberg 1996 Noncompetitive NMDA channel blockade during waking intensely stimulates NREM delta J Pharmacol Exp Ther 276 737 742 1:CAS:528:DyaK28XhtFaktLo%3D 8632344
13. E Casteleijn J Kuiper HC Van Rooij JA Kamps JF Koster TJ Van Berkel 1988 Prostaglandin D2 mediates the stimulation of glycogenolysis in the liver by phorbol ester Biochem J 250 77 80 1:CAS:528:DyaL1cXovVGjug%3D%3D 3162673
14. PH Chan 2001 Reactive oxygen radicals in signaling and damage in the ischemic brain J Cereb Blood Flow Metab 21 2 14 10.1097/00004647-200101000-00002 10.1097/00004647-200101000-00002 1:CAS:528:DC%2BD3MXntFKjtLc%3D 11149664
15. K Cheng TJ Wu KK Wu C Sturino K Metters K Gottesdiener SD Wright Z Wang G O'Neill E Lai, et al. 2006 Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans Proc Natl Acad Sci U S A 103 6682 6687 10.1073/pnas.0601574103 10.1073/pnas.0601574103 1:CAS:528:DC%2BD28XksVKrtLY%3D 16617107
16. SA Cohen WE Muller 1992 Age-related alterations of NMDA-receptor properties in the mouse forebrain: partial restoration by chronic phosphatidylserine treatment Brain Res 584 174 180 10.1016/0006-8993(92)90892-D 1:CAS:528:DyaK38XlsVegsLc%3D 1355390
17. H Darius J Michael-Hepp KH Thierauch A Fisch 1994 Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182 Eur J Pharmacol 258 207 213 10.1016/0014-2999(94)90482-0 1:CAS:528:DyaK2cXksFSltLs%3D 7522176
18. DL Dickstein D Kabaso AB Rocher JI Luebke SL Wearne PR Hof 2007 Changes in the structural complexity of the aged brain Aging Cell 6 275 284 10.1111/j.1474-9726.2007.00289.x 1:CAS:528:DC%2BD2sXntVKqu7o%3D 17465981
19. 2 receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following β-amyloid exposure Eur J Neurosci 22 2199 2206 10.1111/j.1460-9568.2005.04427.x 10.1111/j.1460-9568.2005.04427.x 16262658
20. N Eguchi T Minami N Shirafuji Y Kanaoka T Tanaka A Nagata N Yoshida Y Urade S Ito O Hayaishi 1999 Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice Proc Natl Acad Sci U S A 96 726 730 10.1073/pnas.96.2.726 1:CAS:528:DyaK1MXmtlCruw%3D%3D 9892701
21. M Endres B Engelhardt J Koistinaho O Lindvall S Meairs JP Mohr A Planas N Rothwell M Schwaninger ME Schwab, et al. 2008 Improving outcome after stroke: overcoming the translational roadblock Cerebrovasc Dis 25 268 278 10.1159/000118039 10.1159/000118039 18292653
22. E Gelir SO Arslan H Sayan L Pinar 2005 Effect of rapid-eye-movement sleep deprivation on rat hypothalamic prostaglandins Prostaglandins Leukot Essent Fatty Acids 73 391 396 10.1016/j.plefa.2005.05.021 10.1016/j.plefa.2005.05.021 1:CAS:528:DC%2BD2MXhtVKjsLvJ 16039105
23. H Giles P Leff ML Bolofo MG Kelly AD Robertson 1989 The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist Br J Pharmacol 96 291 300 1:CAS:528:DyaL1MXht12iu7w%3D 2924081
24. DJ Graham D Campen R Hui M Spence C Cheetham G Levy S Shoor WA Ray 2005 Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study Lancet 365 475 481 10.1016/S0140-6736(05)17864-7 1:CAS:528:DC%2BD2MXhtlSgt70%3D 15705456
25. S Hamid-Bloomfield BJ Whittle 1989 Antagonism of PGD2 vasodepressor responses in the rat in vivo by the novel, selective antagonist, BW A868C Br J Pharmacol 96 307 312 1:CAS:528:DyaL1MXht12iu7o%3D 2647205
26. 2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1 J Immunol 171 3936 3940 1:CAS:528:DC%2BD3sXnvVOks70%3D 14530310
27. J Hartikka M Staufenbiel H Lubbert 1992 Cyclic AMP, but not basic FGF, increases the in vitro survival of mesencephalic dopaminergic neurons and protects them from MPP(+)-induced degeneration J Neurosci Res 32 190 201 10.1002/jnr.490320208 1:CAS:528:DyaK38XksVWisb8%3D 1357186
28. AN Hata RM Breyer 2004 Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation Pharmacol Ther 103 147 166 10.1016/j.pharmthera.2004.06.003 10.1016/j.pharmthera.2004.06.003 1:CAS:528:DC%2BD2cXnsFSqtL8%3D 15369681
29. 2 system J Appl Physiol 92 863 868 10.1152/japplphysiol.00766.2001 1:CAS:528:DC%2BD38XhtlSqu7s%3D 11796702
30. O Hayaishi Y Urade 2002 Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives Neuroscientist 8 12 15 10.1177/107385840200800105 10.1177/107385840200800105 1:CAS:528:DC%2BD38Xht1ylsbw%3D 11843094
31. H Hirai K Tanaka O Yoshie K Ogawa K Kenmotsu Y Takamori M Ichimasa K Sugamura M Nakamura S Takano, et al. 2001 Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2 J Exp Med 193 255 261 10.1084/jem.193.2.255 1:CAS:528:DC%2BD3MXksl2msg%3D%3D 11208866
32. R Ientile A De Sarro D Rotiroti GB De Sarro G Nistico 1983 Stimulation of rat caudate nucleus adenylate cyclase activity by BW 245 C, a prostaglandin analogue with prostacyclin-like activity J Pharm Pharmacol 35 62 64 1:CAS:528:DyaL3sXktlelsrg%3D 6131972
33. S Ito S Narumiya O Hayaishi 1989 Prostaglandin D2: a biochemical perspective Prostaglandins Leukot Essent Fatty Acids 37 219 234 10.1016/0952-3278(89)90033-1 1:CAS:528:DyaL1MXlvVOltr0%3D 2510183
34. SB Kandasamy WA Hunt 1990 Involvement of prostaglandins and histamine in radiation-induced temperature responses in rats Radiat Res 121 84 90 10.2307/3577568 1:CAS:528:DyaK3cXhtFCqtrc%3D 2300672
35. M Kiriyama F Ushikubi T Kobayashi M Hirata Y Sugimoto S Narumiya 1997 Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells Br J Pharmacol 122 217 224 10.1038/sj.bjp. 0701367 10.1038/sj.bjp.0701367 1:CAS:528: DyaK2sXmtlynurs%3D 9313928
36. KA Koch JL Wessale R Moreland GA Reinhart BF Cox 2005 Effects of BW245C, a prostaglandin DP receptor agonist, on systemic and regional haemodynamics in the anaesthetized rat Clin Exp Pharmacol Physiol 32 931 935 10.1111/j.1440-1681. 2005.04287.x 10.1111/j.1440-1681.2005.04287.x 1:CAS:528:DC%2BD2MXht1CgsLjP 16405449
37. 2 mediates neuronal protection via the DP1 receptor J Neurochem 92 477 486 10.1111/j.1471-4159.2004.02870.x 10.1111/j.1471-4159.2004.02870.x 1:CAS:528:DC%2BD2MXht12ms7k%3D 15659218
38. KR Magnusson CW Cotman 1993 Age-related changes in excitatory amino acid receptors in two mouse strains Neurobiol Aging 14 197 206 10.1016/0197-4580(93) 90001-R 1:CAS:528:DyaK3sXmtFOqt7c%3D 8391661
39. 2 receptor stimulation elicits ocular hypotensive effects in rabbits and cats Eur J Pharmacol 275 245 250 10.1016/0014-2999(94) 00788-9 10.1016/0014-2999(94)00788-9 1:CAS:528:DyaK2MXks1KgtL8%3D 7768291
40. T Matsuoka M Hirata H Tanaka Y Takahashi T Murata K Kabashima Y Sugimoto T Kobayashi F Ushikubi Y Aze, et al. 2000 Prostaglandin D2 as a mediator of allergic asthma Science 287 2013 2017 10.1126/science.287.5460.2013 10.1126/science.287.5460.2013 1:CAS:528:DC%2BD3cXhvF2qsr0%3D 10720327
41. MP Mattson PB Guthrie SB Kater 1988 Intracellular messengers in the generation and degeneration of hippocampal neuroarchitecture J Neurosci Res 21 447 464 10.1002/jnr.490210236 1:CAS:528:DyaL1MXmvFyrsA%3D%3D 2905749
42. 2 EP2 receptor in cerebral ischemia J Neurosci 24 257 268 10.1523/JNEUROSCI.4485-03.2004 10.1523/JNEUROSCI.4485-03.2004 1:CAS:528:DC%2BD2cXotF2ltQ%3D%3D 14715958
43. A Mizoguchi N Eguchi K Kimura Y Kiyohara WM Qu ZL Huang T Mochizuki M Lazarus T Kobayashi T Kaneko, et al. 2001 Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep Proc Natl Acad Sci U S A 98 11674 11679 10.1073/pnas.201398898 10.1073/pnas.201398898 1:CAS:528:DC%2BD3MXnt12jsLY%3D 11562489
44. Moore LE, Traystman RJ (1994) Role of oxygen free radicals and lipid peroxidation in cerebral reperfusion injury. In: Bosnjak ZJ, August JT (eds) Adv Pharmacol. Academic, San Diego, pp 565-576
45. S Narumiya GA FitzGerald 2001 Genetic and pharmacological analysis of prostanoid receptor function J Clin Invest 108 25 30 1:CAS:528: DC%2BD3MXkvVarsrY%3D 11435452
46. S Narumiya N Toda 1985 Different responsiveness of prostaglandin D2-sensitive systems to prostaglandin D2 and its analogues Br J Pharmacol 85 367 375 2992661
47. S Narumiya T Ogorochi K Nakao O Hayaishi 1982 Prostaglandin D2 in rat brain, spinal cord and pituitary: basal level and regional distribution Life Sci 31 2093 2103 10.1016/0024-3205(82)90101-1 1:CAS:528:DyaL38XlvFehtr8%3D 6960222
48. S Narumiya Y Sugimoto F Ushikubi 1999 Prostanoid receptors: structures, properties, and functions Physiol Rev 79 1193 1226 1:CAS:528:DyaK1MXmvVymtL0%3D 10508233
49. F Obal Jr JM Krueger 2003 Biochemical regulation of non-rapid-eye- movement sleep Front Biosci 8 d520 d550 10.2741/1033 1:CAS:528: DC%2BD3sXjvVWltLg%3D 12700031
50. T Ogorochi S Narumiya N Mizuno K Yamashita H Miyazaki O Hayaishi 1984 Regional distribution of prostaglandins D2, E2, and F2 alpha and related enzymes in postmortem human brain J Neurochem 43 71 82 10.1111/j.1471-4159.1984. tb06680.x 1:CAS:528:DyaL2cXksV2htbw%3D 6427411
51. C Peterson CW Cotman 1989 Strain-dependent decrease in glutamate binding to the N-methyl-d-aspartic acid receptor during aging Neurosci Lett 104 309 313 10.1016/0304-3940(89)90594-6 1:CAS:528:DyaL1MXmt1GktL8%3D 2573018
52. P Rangachari P Betti E Prior R Ln 1995 Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor? J Pharmacol Exp Ther 275 611 617 1:CAS:528:DyaK2MXpsF2hur4%3D 7473146
53. W Rosamond K Flegal K Furie A Go K Greenlund N Haase SM Hailpern M Ho V Howard B Kissela, et al. 2008 Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 117 e25 e146 10.1161/CIRCULATIONAHA.107. 187998 10.1161/CIRCULATIONAHA.107.187998 18086926
54. 2 DP1 receptor protects brain from ischemia-reperfusion injury Eur J Neurosci 26 73 78 10.1111/j.1460-9568.2007. 05627.x 10.1111/j.1460-9568.2007.05627.x 17573924
55. S Saleem ZA Shah Y Urade S Doré 2009 Lipocalin-prostaglandin D synthase is a critical beneficial factor in transient and permanent focal cerebral ischemia Neuroscience 160 248 254 10.1016/j.neuroscience.2009.02.039 10.1016/j.neuroscience.2009.02.039 1:CAS:528:DC%2BD1MXksVaksb0%3D 19254753
56. H Sandig D Andrew AA Barnes I Sabroe J Pease 2006 9α, 11β-PGF2 and its stereoisomer PGF2α are novel agonists of the chemoattractant receptor, CRTH2 FEBS Lett 580 373 379 10.1016/j.febslet.2005.11.052 10.1016/j.febslet.2005.11.052 1:CAS:528:DC%2BD28XmslWnsQ%3D%3D 16378605
57. P Saransaari SS Oja 1995 Age-related changes in the uptake and release of glutamate and aspartate in the mouse brain Mech Ageing Dev 81 61 71 10.1016/0047-6374(95)01583-L 1:CAS:528:DyaK2MXotFGhu7o%3D 8569281
58. 2 receptor, CRTH2 Br J Pharmacol 137 1163 1172 10.1038/sj.bjp. 0704973 10.1038/sj.bjp.0704973 1:CAS:528:DC%2BD3sXktlSj 12466225
59. G Segovia A Porras A Del Arco F Mora 2001 Glutamatergic neurotransmission in aging: a critical perspective Mech Ageing Dev 122 1 29 10.1016/S0047- 6374(00)00225-6 1:CAS:528:DC%2BD3MXksVWltA%3D%3D 11163621
60. H Shirahase M Kanda S Nakamura T Tarumi Y Uehara A Ichikawa 2000 Inhibitory effects of PGD2, PGJ2 and 15-deoxy-Δ12, 14-PGJ2 on iNOS induction in rat mesenteric artery Life Sci 66 2173 2182 10.1016/S0024-3205(00) 00544-0 10.1016/S0024-3205(00)00544-0 1:CAS:528:DC%2BD3cXivFSju7g%3D 10834301
61. AL Siren 1982 Central cardiovascular and thermal effects of prostaglandin D2 in rats Prostaglandins Leukot Med 8 349 359 10.1016/0262-1746(82)90058-0 1:CAS:528:DyaL38XksFSgurY%3D 6955803
62. L Sklair-Tavron M Segal 1993 Neurotrophic effects of cAMP generating systems on central noradrenergic neurons Brain Res 614 257 269 10.1016/0006-8993(93)91043-R 10.1016/0006-8993(93)91043-R 1:CAS:528: DyaK3sXks1ektLw%3D 8102314
63. I Spik C Brenuchon V Angeli D Staumont S Fleury M Capron F Trottein D Dombrowicz 2005 Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse J Immunol 174 3703 3708 1:CAS:528: DC%2BD2MXitVeht7c%3D 15749909
64. S Sturzebecher B Nieuweboer S Matthes E Schillinger 1989 Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gel filtered platelets Prog Clin Biol Res 301 365 369 1:STN:280:DyaK3c%2FhslKhtg%3D%3D 2477855
65. M Toyomoto M Ohta K Okumura H Yano K Matsumoto S Inoue K Hayashi K Ikeda 2004 Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures FEBS Lett 562 211 215 10.1016/S0014-5793(04)00246-7 10.1016/S0014-5793(04)00246-7 1:CAS:528:DC%2BD2cXisVKktro%3D 15044028
66. Y Urade O Hayaishi 1999 Prostaglandin D2 and sleep regulation Biochim Biophys Acta 1436 606 615 10.1016/S0005-2760(98)00163-5 1:CAS:528: DyaK1MXptVGqsQ%3D%3D 9989291
67. L Walch C Labat JP Gascard V de Montpreville C Brink X Norel 1999 Prostanoid receptors involved in the relaxation of human pulmonary vessels Br J Pharmacol 126 859 866 10.1038/sj.bjp. 0702393 10.1038/sj.bjp.0702393 1:CAS:528:DyaK1MXhvVyms7s%3D 10193765
68. GL Wenk LC Walker DL Price LC Cork 1991 Loss of NMDA, but not GABA-A, binding in the brains of aged rats and monkeys Neurobiol Aging 12 93 98 10.1016/0197-4580(91)90047-N 1:CAS:528:DyaK3MXlt1yjs70%3D 1646968
69. BJ Whittle S Moncada K Mullane JR Vane 1983 Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue Prostaglandins 25 205 223 10.1016/0090-6980(83)90105-3 1:CAS:528:DyaL3sXhtlyhsr0%3D 6344147
70. DH Wright KM Metters M Abramovitz AW Ford-Hutchinson 1998 Characterization of the recombinant human prostanoid DP receptor and identification of L-644, 698, a novel selective DP agonist Br J Pharmacol 123 1317 1324 10.1038/sj.bjp. 0701708 10.1038/sj.bjp.0701708 1:CAS:528: DyaK1cXisFGluro%3D 9579725